image
mobile_image
image_caption
eyebrow
headline
It’s time to ask about VELSIPITY—
one pill, once a day.
subheadline
content
disclaimer
content2
disclaimer2
buttons
icon
headline
A treatment option for moderate to severe UC with safety data* and proven efficacy†
subheadline
content
*VELSIPITY safety was studied across 3 different clinical trials and efficacy was studied in 2 trials in people with moderate to severe ulcerative colitis who had trouble tolerating, were not fully responding, or had a loss of response to previous treatments such as steroids, 5-ASAs‡ like mesalamine, biologics, or Janus kinase (JAK) inhibitors.
†Some saw remission by Week 12 and Week 52.
‡5-ASAs are 5-aminosalicylic acid derivatives.
disclaimer
buttons
headline
Here are some things VELSIPITY may do:
subheadline
content
eyebrow
disclaimer
card_identifier
Mobile_image
heading
Quickly treat flares: Some saw remission by week 12. Some saw fewer bathroom trips in 2 weeks and less rectal bleeding in 4 weeks.
body
icon
headline
More people on VELSIPITY achieved clinical remission* in just 3 months versus those taking the placebo.
subheadline
disclaimer
buttons
eyebrow
headline
headline2
content
*Clinical remission means that the symptoms of the disease have improved or disappeared. During remission, you may experience fewer or no episodes of stool frequency and/or rectal bleeding. It’s important to remember that remission doesn’t mean you are cured, and you still need to follow your doctor’s advice to keep the disease under control and help prevent flare-ups.
content2
buttons
Cta_brightcove_account_id
Cta_brightcove_video_id
disclaimer
image
Mobile_image
eyebrow
headline
VELSIPITY works in a different way than most UC therapies.
subheadline
content
How VELSIPITY works is not fully known.
buttons
content2
disclaimer
Image_disclaimer
Brightcove_video_id
Brightcove_account_id
headline
Explore the details of VELSIPITY.
headline2
content
Click on a subject to learn more.
eyebrow
disclaimer
image
Mobile_image
eyebrow
headline
The safety of VELSIPITY was studied in a clinical program with 577 participants across 3 placebo-controlled studies.
subheadline
content
buttons
content2
disclaimer
Image_disclaimer
Brightcove_video_id
Brightcove_account_id
image
Mobile_image
eyebrow
headline
Not a steroid. Not a biologic. VELSIPITY is an option for moderate to severe UC that's in the middle.
subheadline
content
buttons
content2
disclaimer
Image_disclaimer
Brightcove_video_id
Brightcove_account_id
image
Mobile_image
eyebrow
headline
Support and savings to help eligible patients get started on treatment
subheadline
content
buttons
content2
disclaimer
Image_disclaimer
Brightcove_video_id
Brightcove_account_id
headline
Want to learn more about VELSIPITY?
headline2
content
eyebrow
disclaimer
card_identifier
Mobile_image
Image_caption
heading
Discover questions you may want to ask your doctor and more information about VELSIPITY.
body
card_identifier
Mobile_image
Image_caption
heading
Download a printable checklist to help you get started on VELSIPITY.
body
image
Mobile_image
eyebrow
headline
Stay informed about VELSIPITY
subheadline
content
buttons
content2
disclaimer
Image_disclaimer
Brightcove_video_id
Brightcove_account_id